The Annals the journal of Pharmacy Technology
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


The Annals of Pharmacotherapy: Vol. 29, No. 12, pp. 1202-1207.
© 1995 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Preston, S.
Right arrow Articles by Drusano, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Preston, S.
Right arrow Articles by Drusano, G.


Research Articles

Dosing adjustment of 10 antimicrobials for patients with renal impairment

SL Preston, LL Briceland, BM Lomaestro, TS Lesar, GR Bailie, and GL Drusano

OBJECTIVE: To describe a program of creatinine clearance-based dosage adjustment of 10 renally eliminated antimicrobial agents and to discuss the utility of such a program in a hospital as a method of quality assurance (by ensuring that patients with renal impairment receive generally accepted dosage adjustments), based on pharmacodynamic principles. METHODS: Consecutive patients prescribed any of 10 targeted renally eliminated antibiotics were included. Recommendations for dosage adjustment were made to the prescriber based on a calculated creatinine clearance. Additional adjustments in drug therapy were performed, including dosage recommendations of nontargeted drugs, simplification of antibiotic regimens, and conversion of intravenous to oral therapy. A cost analysis was performed. RESULTS: During a 6-month study period, 160 dosage changes (7.6% of total number screened) were recommended in 137 patients receiving the targeted antimicrobial agents. Prescribers accepted 147 recommendations (91.9%). A dosage change recommendation was necessary more than 12% of the time for acyclovir, ceftazidime, and imipenem/cilastatin. A cost avoidance of $11,702.08 was realized. Ancillary drug recommendations that were offered and accepted during the program realized a cost avoidance of $6613.75. CONCLUSIONS: This dosage adjustment program using pharmacodynamic principles was successful in optimization of dosing, potential minimization of morbidity caused by excessive dosing, and demonstration of direct and potentially indirect cost avoidance. A dosing program for patients with renal impairment would be of benefit to other clinicians and institutions seeking to optimize patient care.


This article has been cited by other articles:


Home page
Int J Qual Health CareHome page
L. SALOMON, G. DERAY, M. C. JAUDON, C. CHEBASSIER, P. BOSSI, V. LAUNAY-VACHER, B. DIQUET, J. M. CEZA, S. LEVU, G. BRUCKER, et al.
Medication misuse in hospitalized patients with renal impairment
Int. J. Qual. Health Care, August 1, 2003; 15(4): 331 - 335.
[Abstract] [Full Text] [PDF]


Home page
Int J Qual Health CareHome page
L. SALOMON, S. LEVU, G. DERAY, V. LAUNAY-VACHER, G. BRUCKER, and P. RAVAUD
Assessing residents' prescribing behavior in renal impairment
Int. J. Qual. Health Care, May 1, 2003; 15(3): 235 - 240.
[Abstract] [Full Text] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 1995 by Harvey Whitney Books Company.